Phototherapy with topical minoxidil in vitiligo:A Randomised control trial

Phototherapy with topical minoxidil in vitiligo: Randomised control trial

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/059079

Enrollment

Registered

2023-10-25

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Use of topical minoxidil in vitiligo vulgaris: • Patients will be given the standard therapy for vitiligo along with NB-UVB phototherapy. Two identical lesions on either side of the bod

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed cases of Vitiligo

Exclusion criteria

Exclusion criteria: 1.Pregnant and Lactating Females. 2.Patients with immunocompromised state. 3.Females with Vitiligo patches on Face 4.Patients with photosensitive disorders. 5.Patients who do not want increased hair growth over the lesions 6.Patients who are allergic to minoxidil or are unable to tolerate minoxidil. 7.Patients with depigmented hair on the lesions.

Design outcomes

Primary

Measure	Time frame
Repigmentation of test patchTimepoint: 3 months	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactSejal Bajoria

Kalinga Institute of Medical Sciences

chakravarthi.srinivas74@gmail.com9894625702

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026